Skip to content

Author

Mikel Sánchez

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

An Adaptable Quality Control Framework for Platelet-Rich Plasma as a Blood-Derived Product: A Multicenter Real-World Study

Background and Objectives: Platelet-rich plasma (PRP) composition and activity vary with patient-related factors, medication exposure, and preparation procedures. We developed an adaptable manufacturing quality control score (QC-Score) framework and retained clinical outcomes as a secondary exploratory layer. Methods:...

Pedro Martí Picó, Diego Delgado, María Cayuela et al. · 0 citations
Review Open access Sep 2026

Are Platelet Volume, Density, and the Homeostatic Blueprint the Missing Link in Platelet-Rich Plasma Therapies? An Evidence-Based Narrative Review

Background/Objectives: Platelet-rich plasma (PRP) has been extensively used in clinical practice to treat musculoskeletal (MSK) and spinal maladies. PRP applications and preparation methods focus on variables such as delivery technique, formulation, and device performance. Few PRP preparation methods consider the varia...

P. Everts, Luga Podesta, J. Fitzpatrick et al. · 0 citations
Open access Oct 2026

Extraplatelet Molecule Enrichment Enhances the Ability of Platelet-Rich Plasma Releasate to Buffer IL-1β-Induced Inflammation and Oxidative Stress in a Primary Human Chondrocyte–Synoviocyte Co-Culture In Vitro System of Osteoarthritis

To evaluate the anti-inflammatory and antioxidant effects of standard platelet-rich plasma (sPRP) and balanced protein-concentrate plasma (BPCP), which is a next-generation formulation enriched in platelet-derived and extraplatelet bioactive molecules, in an indirect co-culture model of primary human chondrocytes (hCh)...

Daniel Marijuan-Pinel, Jon Mercader-Ruiz, Xabier Sansinanea et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.